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Abstract
Streptococcus suis is a major swine pathogen and important zoonotic agent causing mainly septicemia and
meningitis. However, the mechanisms involved in host innate and adaptive immune responses toward S. suis as well
as the mechanisms used by S. suis to subvert these responses are unknown. Here, and for the first time, the ability of
S. suis to interact with bone marrow-derived swine dendritic cells (DCs) was evaluated. In addition, the role of S. suis
capsular polysaccharide in modulation of DC functions was also assessed. Well encapsulated S. suis was relatively
resistant to phagocytosis, but it increased the relative expression of Toll-like receptors 2 and 6 and triggered the
release of several cytokines by DCs, including IL-1b, IL-6, IL-8, IL-12p40 and TNF-a. The capsular polysaccharide was
shown to interfere with DC phagocytosis; however, once internalized, S. suis was readily destroyed by DCs
independently of the presence of the capsular polysaccharide. Cell wall components were mainly responsible for DC
activation, since the capsular polysaccharide-negative mutant induced higher cytokine levels than the wild-type
strain. The capsular polysaccharide also interfered with the expression of the co-stimulatory molecules CD80/86 and
MHC-II on DCs. To conclude, our results show for the first time that S. suis interacts with swine origin DCs and
suggest that these cells might play a role in the development of host innate and adaptive immunity during an
infection with S. suis serotype 2.
Introduction
Streptococcus suis is a major swine pathogen associated
mainly with meningitis, although other pathologies have
also been described such as septicemia with sudden death,
endocarditis, arthritis, and pneumonia [1]. Among 35
serotypes described, serotype 2 is considered the most
virulent and the most frequently isolated from both dis-
eased pigs and humans. Consequently, most studies on
virulence factors and the pathogenesis of infection have
been carried out with this serotype [2]. Until recently,
S. suis disease in humans has been considered as rare and
only affecting people working with pigs or pork by-
products. However, with a rising incidence in humans
over the last years, S. suis is now considered as an impor-
tant emerging zoonotic agent, especially in Asian coun-
tries, where S. suis has recently been identified as the
leading cause of adult meningitis in Vietnam, the second
in Thailand, and the third in Hong Kong. In 2005, an
important outbreak occurred in China and resulted in 200
human cases with a fatality rate near 20% [1]. In humans,
S. suis is mainly responsible for meningitis, septicemia and
streptococcal toxic shock-like syndrome [1,3,4].
Despite the increasing number of studies, the patho-
genesis of the S. suis infection is still not completely
understood and, to date, attempts to control the infection
are hampered by the lack of an effective vaccine. The
mechanisms involved in the host innate and adaptive
immune responses toward S. suis as well as those used by
S. suis to subvert these responses are unknown. Several
virulence factors have been proposed to be involved in
the pathogenesis of S. suis infection [5]. Among them,
the capsular polysaccharide, which confers to the bacteria
antiphagocytic properties, has been demonstrated as a
critical virulence factor [2,6,7] and its structure was
recently described [8]. In fact, non-encapsulated mutants
were shown to be avirulent in mice and pig models of
infection [2]. Among several proteins and enzymes, a
hemolysin (suilysin) has been characterized [5,9]. The
suilysin has been described to be involved in the
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any medium, provided the original work is properly cited.modulation of S. suis interactions with host cells, such as
endothelial cells, epithelial cells, neutrophils and mono-
cytes/macrophages [2,5].
Dendritic cells (DCs) are powerful antigen presenting
cells that initiate the immune response against pathogens,
and interactions between DCs and pathogens can strongly
influence the outcome of a disease. After the capture of
antigens, DCs undergo a complex maturation process,
noticeable by the release of cytokines and the increased
expression of co-stimulatory molecules. Mature DCs then
migrate to the adjacent lymphoid organs where they acti-
vate T cells [10]. Thus, DCs are an essential link between
innate and adaptive immunity.
DCs express a wide variety of pattern-recognition recep-
tors (PRRs) that enable them to detect the presence of sev-
eral pathogens through the recognition of pathogen-
associated molecular patterns (PAMPs). Among these
PRRs, Toll-like receptors (TLRs) are important for the
recognition of pathogens and the initiation of the immune
response as well as the shaping of adaptive immunity [11].
Different TLRs recognize different PAMPs of microorgan-
isms. PAMPs recognized specifically by TLR2 include bac-
terial lipopeptides, peptidoglycan and lipoteichoic acid
from Gram-positive bacteria. However, the recognition of
peptidoglycan by TLR2 is still controversial. TLR2 gener-
ally forms heterodimers with TLR1 or TLR6 [12]. TLR4
has been reported as important for the recognition of lipo-
polysaccharide (LPS), a component of the outer mem-
brane of Gram-negative bacteria [12]. Interestingly, TLR4
was also demonstrated as being involved in the recogni-
tion of pneumolysin, a suilysin-related toxin produced by
Streptococcus pneumoniae [13,14].
In the present study, we used porcine bone marrow-
derived DCs to investigate the capacity of S. suis to inter-
act with DCs and to induce their maturation and activa-
t i o n .W ea l s oe x a m i n e dt h ec o n t r i b u t i o no fS. suis
capsular polysaccharide on these interactions. To our
knowledge, this is the first study concerning in vitro cul-
tured porcine DC interactions with a whole live bacterial
swine pathogen.
Materials and methods
Bacterial strains and growth conditions
The S. suis serotype 2 virulent suilysin-positive strain
31533, originally isolated from a case of porcine meningi-
tis, and its isogenic non-encapsulated mutant B218 were
used. These strains were already used in previous studies
[15-17]. S. suis strains were grown as previously
described [17] using either Todd-Hewitt broth (THB) or
agar (THA) (Becton Dickinson, MD, USA) or sheep
blood agar plates at 37°C. To perform S. suis-DCs inter-
action studies, isolated colonies were used as inocula for
THB, which was incubated 8 h at 37°C with shaking.
Working cultures were obtained by inoculating 10 μLo f
a1 0
-3 dilution of these cultures in 30 mL of THB and
incubating for 16 h at 37°C with shaking. Bacteria were
washed twice in phosphate-buffered saline (PBS, pH 7.3)
and were appropriately diluted in complete cell culture
medium for the experiments. The number of CFU/mL in
the final suspension was determined by plating samples
onto THA using Autoplate
® 4000 (Spiral Biotech, Nor-
wood, MA, USA).
Animals
Cells were obtained from 6-8 weeks old SPF piglets. The
animals originated from a herd free of major important
diseases such as porcine reproductive and respiratory syn-
drome (PRRS), enzootic pneumonia due to Mycoplasma
hyopneumoniae and clinical disease related to porcine
circovirus. The herd did not have any episode of acute dis-
ease related to S. suis when the samples were taken. All
experiments involving animals were conducted in accor-
dance with the guidelines and policies of the Canadian
Council on Animal Care and the principles set forth in the
Guide for the Care and Use of Laboratory Animals by the
Animal Welfare Committee of the Université de Montréal.
Generation of bone marrow-derived dendritic cells
Bone marrow-derived DCs were produced according to a
technique described elsewhere [18,19]. Briefly, bone mar-
row was removed from femurs of nine different animals.
After red blood cell lysis, total bone marrow cells (5 × 10
6
cells/plate) were cultured in complete medium consisting
of RPMI 1640 supplemented with 10% heat-inactivated
fetal bovine serum (FBS), 2 mM L-Glutamine, 10 mM
HEPES and 100 U/mL Penicillin-Streptomycin. All
reagents were from Gibco (Burlington, ON, Canada).
Complete medium was complemented with 100 ng/mL of
porcine recombinant GM-CSF (Cell Sciences, Canton,
MA, USA). Cells were cultured for eight days at 37°C in a
5% CO2 incubator and were fed on days 3 and 6. On day
8, cells were harvested, washed, and used as immature
DCs for the studies. DC phenotype and purity was con-
firmed by FACS as described below.
Phagocytosis assay and intracellular survival
Bacteria were either non-opsonized or pre-opsonized
using 20% fresh complete normal pig serum in PBS.
Serum was negative for S. suis specific antibodies, using
a strain-specific ELISA as previously described [20].
Opsonization was performed for 30 min at 37°C with
shaking. Phagocytosis (MOI 1:1) was left to proceed for
30 min, 60 min, 90 min, 2 h and 4 h at 37°C with 5%
CO2. After incubation, penicillin G (5 μg/mL) and gen-
tamicin (100 μg/mL) (both from Sigma, Oakville, ON,
Canada) were added into the wells for 1 h to kill extra-
cellular bacteria. Supernatant controls were taken in
every test to confirm that extracellular bacteria were
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ment, cells were washed three times, and sterile water
was added to lyse the cells. To ensure complete cell
lysis, cells were disrupted by scraping the bottom of the
well and by vigorous pipetting. Viable intracellular bac-
teria were determined by quantitative plating of serial
dilutions of the lysates onto THB agar. For intracellular
survival studies, an internalization assay was performed
as described above, except that after a 60 min initial
bacterial-cell contact, gentamycin-penicillin were added
and the treatment was lengthened for different times up
to 5 h. Cells were then processed as described above
and bacteria counted. Results come from at least three
independent experiments.
Confocal microscopy
For confocal microscopy analysis, cells were placed on
coverslips and infected with the S. suis wild-type or its
non-encapsulated mutant strain (MOI:1). After 2 h of
bacteria-cell contact, coverslips were washed with PBS
to remove non-associated bacteria, and cells fixed with
methanol/acetone (80:20) for 20 min at -20°C, washed
and blocked for 10 min. Coverslips were incubated 1 h
with rabbit anti-S. suis serum and with a monoclonal
antibody against swine MHC class II antibody (VMRD,
Pullman, WA, USA). After washing, coverslips were
incubated with the secondary antibodies Alex-Fluor 488
goat anti-rabbit IgG (S. suis) and Alex-Fluor 568 goat
anti-mouse IgG (DC MHC-II) for 30 min, washed and
mounted on glass slides with moviol containing DABCO
and DAPI to stain the nuclei. Secondary antibodies were
from Invitrogen, CA, USA. The polyclonal antiserum
against S. suis serotype 2 recognizes both wild type and
non encapsulated mutants at similar levels and has pre-
viously been used in other studies with the same strains
[21,22].
Electron microscopy analysis
For transmission electron microscopy (TEM) and scan-
ning electron microscopy (SEM), S. suis strains were
incubated with DCs for 4 h or 2 h, respectively. After
two washes with PBS, the samples were fixed for 1 h at
room temperature with 2% (vol/vol) glutaraldehyde in
0.1 M cacodylate buffer (pH 7.3) and were then post-
fixed for 45 min at room temperature with 2% osmium
tetroxide. Samples were then postfixed in 2% (vol/vol)
osmium tetroxide in deionized water. Specimens for
TEM were dehydrated in a graded series of ethanol
solutions and embedded with LR White resin. Thin sec-
t i o n sw e r ec u tw i t had i a m o n dk n i f ea n dw e r ep o s t -
stained with uranyl acetate and lead citrate. Samples
were observed with an electron microscope model JEOL
JEM-1230. Samples for SEM were dehydrated in a
graded series of ethanol solutions and covered with gold
after critical point drying and were examined with a
Hitachi S-3000 N microscope.
In vitro DC stimulation assay
DCs were resuspended and stimulated with S. suis (MOI:
0.001). Supernatants were collected at 16 h after infection
to measure cytokines by ELISA and cells were harvested
for analysis of co-stimulatory molecules by FACS. Lactate
dehydrogenase (LDH) release measurement assay was
used to measure cytotoxicity levels (Promega CytoTox96,
Promega Corporation, Madison, WI, USA) as previously
described [6]. All experiments were conducted under
non-cytotoxic conditions (data not shown). Purified
Escherichia coli 0111:B4 lipopolysaccharide (LPS) at
1 μg/mL (InvivoGen, San Diego, CA, USA) was used as
positive control.
Cytokine quantification by ELISA
Levels of IL-1b, IL-6, IL-8, IL-12p40 and TNF-a in cell
culture supernatants were measured by sandwich ELISA
using pair-matched antibodies from R&D Systems (Min-
neapolis, MN, USA), according to the manufacturer’s
recommendations. Twofold dilutions of recombinant por-
cine cytokines were used to generate the standard curves.
Sample dilutions giving optical density readings in the lin-
ear portion of the appropriate standard curve were used to
quantify the levels of each cytokine. The results are from
at least three independent experiments with at least two
technical replicates.
FACS analysis
DCs were phenotypically characterized for the following
markers: SWC3, MHC-I, MHC-II, CD1c, CD4, CD11R1,
CD14, CD16, CD80/86 and CD163, and were shown
to be composed of SWC3
+/MHC-I
+/MHC-II
+/CD1c
+/
CD14
+/CD16
+/CD163
low/CD4
-/Cd11R1
- cells, as pre-
viously described [18,19]. Supernatants from hybridomas
were used to detect the presence of the following mole-
cules: SWC3, MHC-I, MHC-II, CD1c, CD4, and CD163.
Hybridomas specific for these swine molecules were used
in previous studies [18,23,24], and provided by Dr J. Dom-
inguez (INIA, Madrid, Spain). Commercially available
monoclonal antibodies from Serotec (Raleigh, NC, USA)
were used to detect CD11R1 (clone MIL4), CD14 (clone
MIL-2) and CD16 (clone G7). Antibodies against CD14
and CD16 were respectively conjugated to PE and FITC. A
soluble fusion protein was used for detection of CD80/86
(CD152/CTLA-4 muIg, Ancell, Bayport, MN, USA).
For cell surface staining, 2.5 × 10
5 cells were incubated
with the appropriate antibody for 1 h on ice followed by
washing and staining for 1 h on ice with the secondary
antibody goat anti-mouse IgG-PE (Jackson Immunore-
search, West Grove, PA, USA). After washing, cells were
resuspended in sorting buffer for FACS analysis. Flow
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ment (BD Biosciences, USA). A total of 20 000 gated
events were acquired per sample and data analysis was
performed using CellQuest software. Quadrants were
drawn based on FITC- and PE-control stains and were
plotted on logarithmic scales. The results are from at
least three independent experiments.
Analysis of TLR gene expression by real time Reverse
Transcriptase-quantitative PCR
DCs were infected with S. suis strains 31533 and B218
(MOI: 0.001) for 2 h, 4 h, 10 h and 16 h. Cells stimulated
with specific ligands of the TLR family were used as
controls. PAM3CSK4 (TLR1/2, final concentration of
500 ng/mL), FSL-1 (TLR2/6, final concentration of
500 ng/mL) and ultra pure LPS (TLR4, final concentration
of 1 μg/mL) were used and were obtained from InvivoGen
(San Diego, CA, USA). Following infection, medium was
removed and cells were washed. Total cellular RNA was
prepared from cells using Trizol reagent (Invitrogen,
Burlington, ON, Canada) according to the manufacturer’s
instructions. Next, 1 μg of total RNA was reverse-
transcribed with the QuantiTect reverse transcription kit
(Qiagen, Mississauga, ON, Canada). The cDNA was
amplified using the SsoFast™ EvaGreen
® Supermix kit
(Bio-Rad, Hercules, CA, USA). The PCR amplification
program for all cDNA consisted of an enzyme activation
step of 3 min at 98°C, followed by 40 cycles of a denatur-
ing step for 2 s at 98°C and an annealing/extension step
for 5 s at 58°C. The primers used for amplification of the
different target cDNA are listed in Table 1 and were all
tested to achieve an amplification efficiency between 90%
and 110%. The primer sequences were all designed from
the NCBI GenBank mRNA sequence using web-based
software primerquest from Integrated DNA technologies
[25]. The Bio-Rad CFX-96 sequence detector was used for
amplification of target cDNA of various TLRs and quanti-
tation of differences between the different groups was cal-
culated using the 2
-ΔΔCt method. Peptidylprolyl isomerase
A (PPIA) was used as the normalizing gene to compensate
for potential differences in cDNA amounts. The non-
infected DC group was used as the calibrator reference in
the analysis. The results are from at least three indepen-
dent experiments.
Statistical analysis
All data are expressed as mean ± SEM. Data from the
phagocytosis assay and ELISA tests were analyzed for
significance using the Student’su n p a i r e dt-test. Data
from RT-PCR were subjected to ANOVA procedures. A
p value < 0.05 was used as threshold for significance. All
experiments were repeated at least three times.
Results
Capsulated S. suis is relatively resistant to phagocytosis
by DCs
To determine the ability of DCs to internalize S. suis, pre-
opsonized or non-opsonized bacteria were incubated with
DCs for different time periods. As shown in Figure 1, the
wild-type strain was relatively resistant to phagocytosis
and relatively few bacteria were found inside the cells. On
the contrary, the non-encapsulated mutant strain was sig-
nificantly more internalized by DCs under non-opsonic
conditions. Thus, the capsular polysaccharide seems to
interfere with the phagocytosis of S. suis by swine DCs.
Serum components did not seem to influence S. suis pha-
gocytosis levels by DCs, as no significant differences were
noticeable between pre-opsonized and non-opsonized
bacteria for either the wild-type strain or the non-
encapsulated mutant (Figure 1).
The ability of DCs to interact and internalize S. suis was
confirmed by confocal and electron microscopy. Confocal
microscopy was performed using serum against S. suis
and an antibody specific for swine MHC-II. DCs were
incubated with either the wild-type strain or the non-
encapsulated mutant. Confocal analysis under non-
opsonic conditions showed that the average number of
internalized bacteria remains very low for the wild-type
strain, with only a few bacterial cells present in every DCs.
In contrast to the wild-type strain, the non-encapsulated
mutant was highly internalized by DCs (Figure 2). No
differences were observed between non-opsonized or pre-
opsonized bacteria (data not shown). For further confirma-
tion of these results, SEM and TEM were carried out.
Indeed, when DCs where incubated with the wild-type
strain, only few cocci were found associated to the cell sur-
face by SEM analysis (Figure 3a). Following incubation
with the non-encapsulated mutant, cocci were largely
found adhering to DCs (Figure 3b-c). TEM analysis
Table 1 Sequences of porcine-specific real-time PCR primers
a
Name Accession Number Forward Reverse
TLR1 NM_001031775 CCAGTGTGTTGCCAATCGCTCATT TCCAGATTTACTGCGGTGCTGACT
TLR2 NM_213761 AGCACTTCCAGCCTCCCTTTAAGT TACTTGCACCACTCGCTCTTCACA
TLR4 NM_001113039 ACCAGACTTTCTTGCAGTGGGTCA AATGACGGCCTCGCTTATCTGACA
TLR6 NM_213760 TCCCAGAATAGGATGCAGTGCCTT ACTCCTTACATATGGGCAGGGCTT
PPIA NM_214353 AGGATTTATGTGCCAGGGTGGTGA ATTTGCCATGGACAAGATGCCAGG
a Oligonucleotide primers were from Integrated DNA Technologies.
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Figure 1 Effect of capsular polysaccharide on the capacity of DCs to internalize S. suis. Bacteria (MOI: 1) were either non-opsonized or
pre-opsonized with 20% complete normal pig serum for 30 min prior to incubation with DCs for 30 min, 60 min, 90 min, 2 h and 4 h. Numbers
of internalized bacteria were determined by quantitative plating after 1 h of antibiotic treatment, and the results are expressed as CFU recovered
bacteria per mL (means ± SEM obtained from independent experiments using DCs derived from nine different animals. Experiments were
repeated at least three independent times). *p < 0.05, indicates statistically significant differences between the wild-type strain 31533 and its
isogenic non-encapsulated mutant either non-opsonized or pre-opsonized with complete normal pig serum. WT, wild-type strain. CPS-, non-
encapsulated mutant.
WT CPS- 
top view 
side view 
Figure 2 Confocal microscopy showing internalization of S. suis. DCs (MOI:1) were incubated with S. suis wild-type strain (WT) or the non-
encapsulated mutant (CPS-). After a bacterial-cell contact of 2 h, cells were fixed and labelled with serum against S. suis (Alex-Fluor 488, green)
and a monoclonal antibody specific for swine MHC-II (Alex-Fluor 568, red). DAPI was used to stain the nuclei (blue).
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cocci despite having been opsonized by complete serum
(Figure 4a). In contrast, high numbers of streptococci were
observed intracellularly after DC infection with the non-
encapsulated mutant pre-opsonized with complete serum
(Figure 4b). Altogether, these results suggest that the non-
encapsulated mutant adheres to and is internalized by
DCs at markedly higher numbers than the wild-type
strain.
S. suis is readily destroyed inside DCs
To analyze the intracellular fate of bacteria once inter-
nalized, we modified the phagocytosis assay in order to
quantify bacterial intracellular survival over time. Pre-
cisely, after 60 min incubation of S. suis with DCs, to
get optimal internalization, antibiotics were added and
the treatment was lengthened for different times up to
5 h. As shown in Figure 5, once internalized, both the
wild-type strain and its non-encapsulated mutant were
equally destroyed as shown by similar rates and kinetics
of reduction in intracellular bacterial numbers observed.
Hence, the capsular polysaccharide interferes with
S. suis phagocytosis by DCs, but does not protect the
bacteria against intracellular killing. No differences in
intracellular survival levels were observed between non-
opsonized or pre-opsonized bacteria (data not shown).
Figure 3 Scanning electron micrographs showing interactions between DCs and S. suis. DCs were incubated with S. suis (MOI:1) wild-type
strain (WT) or the non-encapsulated mutant (CPS-) for 2 h. (A) DCs incubated with S. suis WT strain show very few cocci on the cell surface. DCs
incubated with the CPS- mutant show several cocci adhering to the cells (B-C). White arrows show bacterial cells. (A) Scale bar, 10 μm. Original
magnification 5000 ×. (B-C) Scale bar, 5 μm. Original magnification 5000 ×.
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The levels of the pro-inflammatory cytokines IL-1b, IL-6
and TNF-a, the T cell-activating cytokine IL-12p40, and
the chemokine IL-8 in the supernatants of S. suis-
infected DCs were measured at 16 h after stimulation.
Time and bacterial dose for the cytokine stimulation
assays were chosen using the absence of cytotoxicity
and significant activation as the selection criteria (data
not shown). Our results show that DCs produced signif-
icant amounts of these cytokines after exposure to S.
suis wild-type strain compared to control, non-activated
cells. However, the non-encapsulated strain induced sig-
nificantly higher levels of all cytokines tested, except for
IL-1b, compared to the wild-type strain (Figure 6a-e).
Involvement of TLR2 and TLR6 in DC activation by S. suis
To analyze whether S. suis modulates mRNA expression
levels of TLR1, 2, 4 and 6, DCs were stimulated with S.
suis wild-type strain or its non-encapsulated mutant.
PAM(3)CSK, FSL-1 and LPS were used as positive con-
trols for TLR2/TLR1, TLR2/TLR6 and TLR4, respec-
tively. As shown in Figure 7, S. suis wild-type strain
induced significant up-regulation of TLR2 and TLR6
mRNA by DCs at 16 h and 10 h of infection, respec-
tively. Similarly, the non-encapsulated strain activated
both TLR2 and TLR6 within 10 h of infection (Figure
7a-b). As low and variable levels of TLR1 mRNA
expression were observed in S. suis-stimulated DCs, no
significant differences could be observed compared to
non-infected control cells (data not shown). Finally, the
expression of TLR4 was not up-regulated in the pre-
sence of S. suis even though an upregulation was notice-
able with the positive control LPS (data not shown).
Encapsulated S. suis failed to induce DC surface
expression of co-stimulatory molecules
The ability of S. suis to induce surface expression of
the co-stimulatory molecules MHC-II and CD80/86 by
→ 
→ 
↑ 
← 
a  b 
Figure 4 Transmission electron micrographs showing internalization of S. suisby DCs. DCs (MOI:1) were incubated with S. suis wild-
type strain (WT) or the non-encapsulated mutant (CPS-) for 4 h. (A) Most DCs were free of S. suis or contained very few bacteria when
incubated with serum-opsonized WT strain 31533, (B) DCs incubated with serum-opsonized CPS- mutant contained high numbers of internalized
bacteria. White arrows show internalized bacteria, scale bar 2 μm. Original magnification 10000 ×.
WT
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Figure 5 Intracellular survival of S. suis within DCs.D C sw e r e
infected with S. suis (MOI:1) wild-type strain (WT) or the non-
encapsulated mutant (CPS-) and phagocytosis was left to proceed
for 1 h. Antibiotics were then added for a period time of 1 h
(considered here as time 0). This initial antibiotic-treatment was
lengthened for different times up to 5 h and cells were lysed to
quantified intracellular bacteria by viable plate counting. The results
are expressed as CFU recovered intracellular bacteria per mL (means
± SEM obtained from three independent experiments using DCs
derived from nine different animals). An asterisk indicates the
incubation time for which the number of intracellular bacteria
recovered is significantly different (p < 0.05) from number of
intracellular bacteria obtained after an initial 1 h antibiotic treatment
(considered here as time 0).
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(Figure 8). Interestingly, wild-type S. suis failed to
induce significant up-regulation of CD80/86 and
MHC-II expression by DCs in terms of the percentage
of cells expressing these markers compared with non-
stimulated, control cells. In contrast, DCs stimulated
with the non-encapsulated mutant strain showed sig-
nificant higher levels of surface expression of CD80/86
compared with non-stimulated cells and cells stimu-
lated with the wild-type strain. Significantly higher
levels of surface expression of MHC-II were also
observed following DC stimulation with the non-
encapsulated mutant strain compared to non-stimu-
lated cells. It should be noted that high variability was
observed between animals in terms of MHC-II expres-
sion; as such the difference between the wild-type
strain and its non-encapsulated mutant was shown not
to be significant for this molecule. Altogether, our data
suggest that the capsular polysaccharide interferes with
co-stimulatory molecule expression by DCs.
Discussion
S. suis is considered as a zoonotic pathogen of increas-
ing importance for human health [1,3,4]. However,
despite the rising number of studies, mechanisms lead-
ing to an efficient immune response against S. suis are
poorly understood. Previously, we have demonstrated
that the mouse model of infection is a valid model to
reproduce S. suis infection [15,26], and recently, interac-
tions between S. suis and mouse bone marrow-derived
DCs (mDCs) were described [21]. The results show that
S. suis uses an arsenal of different virulence factors to
modulate mDC functions and escape immune surveil-
lance, mainly by modulating cytokine release and escap-
ing opsono-phagocytosis. However, it is important to
confirm S. suis modulation of DC activation in the nat-
ural host, the swine. The present work demonstrates for
the first time that S. suis interacts with porcine DCs and
modulates their maturation and activation.
We used a phagocytosis assay, combined with confocal
and electron microscopy to measure the ability of DCs
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Figure 6 Cytokine production by DCs in response to stimulation by LPS (1 μg/mL) and different S. suis strains (MOI: 0.001) for 16 h.
Data are expressed as mean ± SEM (in ng/mL) from independent experiments using DCs derived from 9 different animals. Experiments were
repeated at least three times with at least two technical replicates. Control, non-infected cells. WT, wild-type strain. CPS-, non-encapsulated
mutant. *p < 0.05, denotes values obtained with the CPS- mutant that are significantly higher than those obtained with the WT strain.
Lecours et al. Veterinary Research 2011, 42:72
http://www.veterinaryresearch.org/content/42/1/72
Page 8 of 12to internalize S. suis and to evaluate the role of the cap-
sular polysaccharide in this process. We observed that
the presence of the capsular polysaccharide protects S.
suis from DC phagocytosis, both under opsonic and
non-opsonic conditions. This confirms the role of the
capsular polysaccharide as an anti-phagocytic factor. In
agreement, previous studies (using the same wild type
and mutant strains included in this study) with mono-
cytes/macrophages, neutrophils and mDCs demon-
strated that the capsular polysaccharide reduces S. suis
phagocytosis [6,7,21,27]. Moreover, the capsular polysac-
charide was also previously shown to be crucial for the
survival of S. suis in vivo. Indeed, the non-encapsulated
mutant strain used in this study was shown to be
avirulent and rapidly eliminated from the bloodstream
in a porcine model of infection [28]. Despite the fact
that the capsular polysaccharide acts as a physical bar-
rier to block S. suis phagocytosis by DCs, the intracellu-
lar survival assay showed that once internalized, both
encapsulated and non-encapsulated strains are equally
destroyed. Our previous data with mDCs showed that
both encapsulated and non-encapsulated S. suis localizes
within LAMP+ vacuoles suggesting phagosome fusion
with lysosomes leading to bacterial destruction [21].
Hence, the capsular polysaccharide protects the bacteria
against phagocytosis, but not against intracellular killing.
Previous studies with macrophages also showed that
neither virulent nor non-virulent encapsulated strains
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Page 9 of 12were able to survive inside macrophages [29,30]. Alto-
gether these studies suggest that S. suis extracellular
localization confers to this pathogen a survival advan-
tage and the capsular polysaccharide is essential to it.
Wild-type S. suis was shown to trigger DC release of IL-
1b, IL-6, IL-8, IL-12p40 and TNF-a.T h e s ec y t o k i n e s ,
among others, were recently shown to be released by
mDCs following stimulation with wild-type S. suis strain
31533 [21]. The capsular polysaccharide interfered with
the release of IL-6, IL-8, IL-12 and TNF-a by swine
DCs, as shown with mDCs and other phagocytic cells
[6,7]. Increased exposure of cell wall components due to
t h ea b s e n c eo fac a p s u l em a ya c c o u n tf o rt h eh i g h e r
capacity of the non-encapsulated mutant to induce most
cytokine secretion, and confirm the role of cell wall
components as major cytokine modulators [17,31,32].
This is further supported by recent results with mDCs
where we observed that IL-12p70, IL-10 and CXCL10
release was diminished following mDC stimulation by S.
suis cell wall mutant strains [21]. Besides S. suis cell
wall components, studies to date have identified two
cytokines for which the capsular polysaccharide is
required for optimal induction, MCP-1 and IL-1b
[21,31,32]. Here, S. suis capsular polysaccharide was also
shown not to interfere with the production of IL-1b
production by swine DCs. The molecular pathways
underlying the capsular polysaccharide contribution to
IL-1b and MCP-1 release are under evaluation. Finally,
and accordingly to data from Devriendt et al., porcine
DCs were low responsive to LPS [33].
In addition to cytokine production, both the wild-type
strain and its non-encapsulated mutant strain increased
the expression of TLR2 and TLR6 mRNA. No differ-
ences were noticeable between the two strains for the
expression of TLR2. However, the expression of TLR6
was increased more rapidly after DC infection with the
non-encapsulated strain than that observed for the wild-
type strain. This activation pattern is in agreement with
that recently reported by Wichgers Schreur et al. [34],
w h os h o w e dt h a th u m a nT L R 2a n dT L R 6a r ea c t i v a t e d
by lipoproteins of S. suis [34]. However, our results
slightly differ from those of these authors who indicate
an absence of TLR2 upregulation after culturing human
transfected epithelial cells with live or heat-killed whole
cells of S. suis. It should be noted, however, that interac-
tions between S. suis and epithelial cells can highly differ
from those observed with DCs. It has also been demon-
strated that stimulation of human monocytes by whole
encapsulated S. suis or its purified cell wall components
influences the relative expression of TLR2 mRNA [31].
Moreover, this stimulation triggered the release of cyto-
kines, which was significantly reduced by neutralizing
antibodies against TLR2 but not against TLR4 [31].
Mouse macrophages deficient in TLR2 expression also
show reduced cytokine release in response to encapsu-
lated S. suis. Since this response was completely inhib-
ited in MyD88-deficient macrophages, other TLRs could
be involved in cytokine production induced by S. suis.
In addition, it was demonstrated that the presence of
the capsular polysaccharide modulates interactions
between S. suis and TLRs, as uncovered cell wall com-
ponents were shown to induce cytokine production
through TLR2-dependent and -independent pathways
[31]. Finally, after S. suis invasion of the central nervous
system, transcriptional activation of TLR2, TLR3 and
CD14 has been observed in a mouse model of infection
[15]. This study is the first to report TLR activation fol-
lowing S. suis stimulation of cells of porcine origin.
The ability of S. suis to induce the maturation of DCs
was also investigated by evaluating the surface expres-
sion of the co-stimulatory molecules CD80/86 and
MHC-II on swine DCs. S. suis wild-type strain failed to
induce the expression of either CD80/86 or MHC-II on
DCs. The capsular polysaccharide was shown to be
responsible for the impaired expression of CD80/86 on
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Figure 8 Expression of surface markers MHC-II and CD80/86 by
DCs stimulated with LPS (1 μg/mL) or S. suis (MOI: 0.001) wild-
type strain (WT) or the non-encapsulated mutant (CPS-) for 16
h. Unstimulated DCs served as control. Data are expressed as mean
± SEM (in % of positive cells) from independent experiments using
DCs derived from 6 different animals. *p < 0.05, denotes values
obtained with the CPS- mutant that are significantly higher from
those obtained with control cells.
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MHC-II expression. This differed with results obtained
with mDCs where wild-type S. suis induced mDC
maturation levels similar to those observed with the
non-encapsulated mutant [21]. These differences could
be related to the cell origin (swine vs. mouse) and also
to the fact that mDC are derived from inbred mouse
lines while swine DCs are originated from outbred ani-
mals. Indeed, high variability was observed in S. suis-
induced MHC-II expression by DCs derived from differ-
ent pigs. This could be related to the fact that genes of
the MHC complex have high levels of polymorphism
[35,36]. Highly polymorphic swine leukocyte antigen
(SLA) genes in the porcine MHC have been shown to
significantly influence swine immunological traits and
vaccine responsiveness [37-40]. The strong influence of
the SLA complex is mostly attributable to the antigen-
presenting properties of the MHC proteins in the swine
adaptive immune system [41]. The high degree of varia-
bility in the ability of DCs to up-regulate surface expres-
sion of MHC-II might explain, in part, why S. suis
would successfully colonize only some piglets and not
others, and why some animals will only be healthy car-
riers and will never develop disease whereas others will
develop bacteremia, sometimes septicemia and finally
meningitis [2]. As individual variation in responsiveness
to vaccine candidates is becoming more of an issue, par-
ticularly with non-responders, these observations are
crucial for the immunological studies of S. suis
pathogenesis.
To conclude, our results show for the first time that S.
suis interacts with swine origin DCs and suggest that these
cells might play a role in the development of host innate
and adaptive immunity during an infection with S. suis
serotype 2. S. suis resists phagocytosis but is able to acti-
vate the release of pro-inflammatory cytokines by DC
mainly through the activation of TLRs 2 and 6. In fact,
S. suis capsular polysaccharide was shown to modulate
most interactions with DCs by protecting bacteria against
phagocytosis, reducing the level of cytokine production
and preventing the surface expression of co-stimulatory
molecules. Overall, capsular polysaccharide-impaired S.
suis interactions with DCs would result in low bacterial
up-take as well as low DC activation and maturation
which might translate in reduced antigen processing and
T cell activation, although this should be confirmed. The
capsular polysaccharide could therefore be considered as
an escape mechanism for S. suis.I ti si m p o r t a n tt on o t e
that since none of the non-encapsulated mutants available
in the literature (including the one used in this study)
could so far be successfully complemented (showing
restoration of capsule production), a certain additional
role of other unknown mutation in those mutants cannot
be completely ruled out. The importance of DCs on the
efficacy of the immune system has been clearly demon-
strated in the last years [42,43]. However, to our knowl-
edge, this study is the first to investigate the interactions
between a whole live bacterial pathogen and swine DCs.
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